Psychopharmacology – A Masters Class 2021 (CME VIDEOS)
Learning Objectives
Upon completion of this activity, participants will be better able to apply:
– Evaluate the effects of neurotransmitters and genes on psychotropic drug treatment
– Study the interface between neurology and psychiatry
– Describe the pharmacologic treatment of schizophrenia with particular reference to the prodromal period and first episode
– Outline the emerging theories and treatments of bipolar disorder, depression, treatment resistant depression, bipolar depression, stress and anxiety disorder
– Discuss the role of psychotropic medications in women’s mental health with an emphasis on PMS, pregnancy, nursing, and the postpartum period
– Review the appropriate use of medications in the treatment of sleep disorders
– Access psychopharmacologic treatment of eating disorders
– Summarize the interface between medicine and psychiatric disorders with an emphasis on cardiovascular disease and cancer
– Review the appropriate use of stimulants in the treatment of attention and ADHD disorders as well as their use as an adjunct to antidepressant treatment
– Identify psychopharmacologic treatment for the borderline personality disorder
– Explain the role of psychopharmacology in the treatment of substance use disorders with particular emphasis on alcohol, opiates, and cannabis
– Recognize when to utilize ECT and TMS for the treatment of depression
– Discuss standard psychopharmacologic treatments that have now been proven to be ineffective
– Give examples of the latest advances and problems associated with treatment approaches in the child, adolescent and geriatric populations
TOPICS / SPEAKERS:
